Abstract

The invention relates to a method for preventing or attenuating one or more complications of intracerebral haemorrhage (ICH), the method comprising: (i) selecting an ICH patient who exhibits one or more of the following characteristics: age≰70, baseline ICH volume≰60 mL, baseline IVH volume≰5 mL, and elapsed time since onset of symptoms of less than about 2.5 hours; and (ii) administering to said patient in need thereof an effective amount of a first coagulation agent comprising Factor VIIa or a Factor VIIa equivalent.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jan 20, 2011
  • Application: Jan 16, 2009
    US US 81268409 A
  • Priority: Jan 16, 2009
    US US 81268409 A
  • Priority: Jan 16, 2009
    EP EP 2009050488 W
  • Priority: Feb 1, 2008
    US US 2538708 P
  • Priority: Jan 25, 2008
    EP EP 08100916 A
  • Priority: Jan 18, 2008
    EP EP 08100633 A

Download Citation


Sign in to the Lens

Feedback